JRJ
TRIB

Jeffrey R. Jay’s Trinity Biotech TRIB Stock Holding History

Jeffrey R. Jay’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$2.75M Buy
+32,628
New +$2.71M 2.17% 14

Other funds holding TRIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
AAM
ACK Asset Management Greenwich, Connecticut $801M AUM 60.42% 1-Year Est. Return
CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LSC
Lyon Street Capital Sausalito, California $67M AUM

Jeffrey R. Jay's TRIB Position: Q2 2013 in Review

Jeffrey R. Jay opened a new position in Trinity Biotech (TRIB) in Q2 2013: 32,628 shares worth $2.75M. The stake represents 2.17% of the portfolio and ranks #14 among its holdings.

64 funds tracked by Wall St. Rank hold TRIB as of Q2 2013.

  • Jeffrey R. Jay held 32,628 shares of Trinity Biotech worth $2.75M as of Q2 2013.
  • Trinity Biotech was a new Jeffrey R. Jay position in Q2 2013.
  • Trinity Biotech made up 2.17% of Jeffrey R. Jay's portfolio in Q2 2013, its #14 holding.
  • 64 funds tracked by Wall St. Rank held Trinity Biotech as of Q2 2013.

Based on Jeffrey R. Jay's 13F filing for Q2 2013, filed 14 Aug 2013.